• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PET/CT for staging lung cancer: costly or cost-saving?

作者信息

Buck Andreas K, Herrmann Ken, Schreyögg Jonas

出版信息

Eur J Nucl Med Mol Imaging. 2011 May;38(5):799-801. doi: 10.1007/s00259-011-1803-3. Epub 2011 Mar 26.

DOI:10.1007/s00259-011-1803-3
PMID:21442260
Abstract
摘要

相似文献

1
PET/CT for staging lung cancer: costly or cost-saving?用于肺癌分期的PET/CT：成本高昂还是节省成本？
Eur J Nucl Med Mol Imaging. 2011 May;38(5):799-801. doi: 10.1007/s00259-011-1803-3. Epub 2011 Mar 26.
2
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.混合正电子发射断层扫描/计算机断层扫描在非小细胞肺癌分期中的成本效益。
J Nucl Med. 2010 Nov;51(11):1668-75. doi: 10.2967/jnumed.109.072090.
3
Cost-effectiveness analysis of strategies introducing integrated ¹⁸F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer.将¹⁸F-FDG PET/CT 集成引入非小细胞肺癌纵隔淋巴结分期策略的成本效益分析。
Nucl Med Commun. 2015 Mar;36(3):234-41. doi: 10.1097/MNM.0000000000000247.
4
PET/CT in non-small cell lung cancer staging-promises and problems.PET/CT在非小细胞肺癌分期中的前景与问题
Clin Radiol. 2007 Feb;62(2):97-108. doi: 10.1016/j.crad.2006.09.015.
5
Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial.肺癌术前 PET/CT 分期：一项随机对照试验的成本效益评估。
Eur J Nucl Med Mol Imaging. 2011 May;38(5):802-9. doi: 10.1007/s00259-010-1703-y. Epub 2011 Jan 6.
6
Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.与常规纵隔镜检查相比，选择性纵隔镜检查的正电子发射断层扫描在非小细胞肺癌术前分期中具有成本和临床结果优势。
Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1033-40. doi: 10.1007/s00259-005-1821-0. Epub 2005 May 5.
7
Cost-effectiveness of positron emission tomography for the management of potentially operable non-small cell lung cancer in Quebec.正电子发射断层扫描在魁北克省对潜在可手术的非小细胞肺癌管理中的成本效益分析
Can Respir J. 2005 Jan-Feb;12(1):19-25. doi: 10.1155/2005/612387.
8
Budget impact from the incorporation of positron emission tomography - computed tomography for staging lung cancers.纳入正电子发射断层扫描-计算机断层扫描用于肺癌分期的预算影响。
Rev Saude Publica. 2015;49:57. doi: 10.1590/S0034-8910.2015049005447. Epub 2015 Aug 11.
9
PET/CT in the staging of the non-small-cell lung cancer.PET/CT在非小细胞肺癌分期中的应用
J Biomed Biotechnol. 2012;2012:783739. doi: 10.1155/2012/783739. Epub 2012 Mar 7.
10
Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.从法国医疗保健系统的角度对将氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）引入非小细胞肺癌纵隔分期的策略进行成本效益分析。
Clin Radiol. 2005 Apr;60(4):479-92. doi: 10.1016/j.crad.2004.10.010.

引用本文的文献

1
The prognostic and clinicopathological value of HALP score in non-small cell lung cancer.HALP评分在非小细胞肺癌中的预后及临床病理价值
Front Immunol. 2025 Jun 26;16:1576326. doi: 10.3389/fimmu.2025.1576326. eCollection 2025.
2
Impact of preoperative [F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study.术前 [F]FDG PET/CT 与增强 CT 对临床Ⅰ期和Ⅱ期非小细胞肺癌患者分期和生存的影响：一项 10 年随访研究。
Ann Nucl Med. 2024 Mar;38(3):188-198. doi: 10.1007/s12149-023-01888-z. Epub 2023 Dec 25.
3

本文引用的文献

1
Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial.肺癌术前 PET/CT 分期：一项随机对照试验的成本效益评估。
Eur J Nucl Med Mol Imaging. 2011 May;38(5):802-9. doi: 10.1007/s00259-010-1703-y. Epub 2011 Jan 6.
2
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.混合正电子发射断层扫描/计算机断层扫描在非小细胞肺癌分期中的成本效益。
J Nucl Med. 2010 Nov;51(11):1668-75. doi: 10.2967/jnumed.109.072090.
3
Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.
Spiking Cortical Model Based Multimodal Medical Image Fusion by Combining Entropy Information with Weber Local Descriptor.
基于尖峰皮层模型的多模态医学图像融合：结合熵信息与韦伯局部描述符
Sensors (Basel). 2016 Sep 15;16(9):1503. doi: 10.3390/s16091503.
4
Added value of cost-utility analysis in simple diagnostic studies of accuracy: (18)F-fluoromethylcholine PET/CT in prostate cancer staging.成本效用分析在简单准确性诊断研究中的附加价值：（18）F-氟甲基胆碱PET/CT在前列腺癌分期中的应用
Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):183-94. eCollection 2015.
5
Positron emission tomography-computed tomography in the management of lung cancer: An update.正电子发射断层扫描-计算机断层扫描在肺癌管理中的应用：最新进展
South Asian J Cancer. 2013 Jul;2(3):171-8. doi: 10.4103/2278-330X.114148.
6
Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer.592例非小细胞肺癌患者初始PET/CT分期对临床分期、治疗方案及预后的影响
Eur J Nucl Med Mol Imaging. 2014 May;41(5):906-14. doi: 10.1007/s00259-013-2672-8. Epub 2014 Jan 18.
7
Measurement of primary tumor volume by PET-CT to evaluate risk of mediastinal nodal involvement in NSCLC patients with clinically negative N2 lymph nodes.通过PET-CT测量原发性肿瘤体积以评估临床N2淋巴结阴性的非小细胞肺癌患者纵隔淋巴结受累风险。
Rep Pract Oncol Radiother. 2013 Jan 5;18(2):76-81. doi: 10.1016/j.rpor.2012.11.002. eCollection 2013.
8
Prospective of ⁶⁸Ga-radiopharmaceutical development.展望 ⁶⁸Ga 放射性药物的发展。
Theranostics. 2013 Dec 10;4(1):47-80. doi: 10.7150/thno.7447.
9
PET/CT in the staging of the non-small-cell lung cancer.PET/CT在非小细胞肺癌分期中的应用
J Biomed Biotechnol. 2012;2012:783739. doi: 10.1155/2012/783739. Epub 2012 Mar 7.
10
PET-CT in the staging and treatment of non-small-cell lung cancer.正电子发射断层扫描 - CT（PET-CT）在非小细胞肺癌分期和治疗中的应用。
Clin Transl Oncol. 2011 Jun;13(6):368-77. doi: 10.1007/s12094-011-0670-5.
1999-2006 年，医疗保险受益人群中癌症患者的诊断性影像学检查的使用和费用变化。
JAMA. 2010 Apr 28;303(16):1625-31. doi: 10.1001/jama.2010.460.
4
Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.肿瘤学中正电子发射断层扫描（PET）和 PET/CT 的经济学评价：证据和方法学方法。
J Nucl Med. 2010 Mar;51(3):401-12. doi: 10.2967/jnumed.108.059584. Epub 2010 Feb 11.
5
Preoperative staging of lung cancer with combined PET-CT.采用PET-CT联合检查对肺癌进行术前分期
N Engl J Med. 2009 Jul 2;361(1):32-9. doi: 10.1056/NEJMoa0900043.
6
Multi-modality mediastinal staging for lung cancer among medicare beneficiaries.医疗保险受益人群中肺癌的多模态纵隔分期
J Thorac Oncol. 2009 Mar;4(3):355-63. doi: 10.1097/JTO.0b013e318197f4d9.
7
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).肺癌的侵袭性纵隔分期：美国胸科医师学会循证临床实践指南（第2版）
Chest. 2007 Sep;132(3 Suppl):202S-220S. doi: 10.1378/chest.07-1362.
8
Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion.非小细胞肺癌的术前分期：正电子发射断层扫描、正电子发射断层扫描/计算机断层扫描一体化及软件图像融合
Chest. 2005 Oct;128(4):2289-97. doi: 10.1378/chest.128.4.2289.
9
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.非小细胞肺癌：18F-FDG PET/CT 与单纯 CT 在术前分期中的前瞻性比较
Radiology. 2005 Sep;236(3):1011-9. doi: 10.1148/radiol.2363041310. Epub 2005 Jul 12.
10
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.正电子发射断层扫描与计算机断层扫描相结合用于非小细胞肺癌分期
N Engl J Med. 2003 Jun 19;348(25):2500-7. doi: 10.1056/NEJMoa022136.